(Q38990219)

English

Effect of Fascioliasis on the pharmacokinetic parameters of triclabendazole in human subjects

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Effect of Fascioliasis on the pharmacokinetic parameters of triclabendazole in human subjects (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

human subject research project

0 references

triclabendazole

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

pharmacokinetics

1 reference

based on heuristic

inferred from title

author name string

Walid H El-Tantawy

1

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Heba F Salem

2

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Nirmeen A S Mohammed Safwat

3

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

language of work or name

0 references

publication date

30 January 2007

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

International Journal of Clinical Pharmacy

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

29

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

190-198

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Triclabendazole for the treatment of fascioliasis and paragonimiasis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17265093

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assay of triclabendazole and its main metabolites in plasma by high-performance liquid chromatography

1 reference

https://pubmed.ncbi.nlm.nih.gov/17265093

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of Kato thick-smear technique for quantitative diagnosis of helminth infections

1 reference

https://pubmed.ncbi.nlm.nih.gov/17265093

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A review on fascioliasis in Egypt.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17265093

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Triclabendazole: new skills to unravel an old(ish) enigma

1 reference

https://pubmed.ncbi.nlm.nih.gov/17265093

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A case of ectopic fascioliasis in a farmer from Mansoura City, Dakahlia, Egypt

1 reference

https://pubmed.ncbi.nlm.nih.gov/17265093

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The kinetics of triclabendazole disposition in sheep

1 reference

https://pubmed.ncbi.nlm.nih.gov/17265093

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of acute toxaemic fascioliasis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17265093

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics and efficacy of long-term low-level administration of triclabendazole in urea molasses blocks against induced bovine and bubaline fasciolosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17265093

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reversed-phase ion-pair high-performance liquid chromatographic determination of triclabendazole metabolites in serum and urine

1 reference

https://pubmed.ncbi.nlm.nih.gov/17265093

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of food on the bioavailability of triclabendazole in patients with fascioliasis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17265093

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Unsuccessful use of praziquantel to treat acute fascioliasis in children

1 reference

https://pubmed.ncbi.nlm.nih.gov/17265093

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of human chronic fascioliasis with triclabendazole: drug efficacy and serologic response

1 reference

https://pubmed.ncbi.nlm.nih.gov/17265093

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The efficacy and pharmacokinetics of long-term low-level intraruminal administration of triclabendazole in buffalo with induced fasciolosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17265093

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Praziquantel and Fasciola hepatica infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/17265093

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and pharmacokinetics of triclabendazole in buffalo with induced fasciolosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17265093

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics and efficacy of triclabendazole in goats with induced fascioliasis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17265093

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of immature and mature Fasciola hepatica infections in sheep with triclabendazole

1 reference

https://pubmed.ncbi.nlm.nih.gov/17265093

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S11096-006-9069-8

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38990219&oldid=2143340609"